原发性骨质疏松症患者应用补肾通络方治疗临床分析.docVIP

原发性骨质疏松症患者应用补肾通络方治疗临床分析 　　[摘要] 目的 研究原发性骨质疏松症患者应用补肾通络方案的临床疗效，为临床治疗提供可参考依据。 方法 抽取我院2012年1月～2014年1月原发性骨质疏松症患者70例，进行研究。按照患者意愿分为研究组和对照组，每组35例。研究组应用补肾通络方案，对照组采用阿法骨化醇治疗。 结果 研究组总有效率为91.43%，对照组总有效率为71.43%，研究组总有效率显著高于对照组（P0.05）；研究组碱性磷酸酶治疗后比治疗前含量显著降低，且低于对照组治疗后（P0.05），研究组骨密度治疗后比治疗前显著增高，且高于对照组治疗后（P0.05）。 结论 应用补肾通络房治疗原发性骨质疏松症临床效果显著，改善实验室骨质检测指标，改善患者预后，可以在临床治疗中推广应用。 　　[关键词] 原发性骨质疏松症；补肾通络；临床疗效 　　[中图分类号] R259 [文献标识码] B [文章编号] 2095-0616（2015）17-90-03 　　Clinical analysis of Bushen Tongluo scheme in treatment of patients with primary osteoporosis 　　GUO Ning GONG Ming YU Dapeng 　　211 Hospital of PLA， Harbin， Heilongjiang， Harbin 150001， China 　　[Abstract] Objective To study clinical curative effect of Bushen Tongluo scheme on patients with primary osteoporosis to provide reference for clinical treatment. Methods 70 patients with primary osteoporosis who were admitted to our hospital from January 2012 to January 2014 were selected and researched. They were allocated to the study group and the control group according to the willing of patients， with 35 in each. The study group was received bushen tongluo scheme while the control group was treated by alfacalcidol. Results The research group Total effective rate of the study group was 91.43%， significantly higher than that of the control group 71.43% （P0.05）. Alkaline phosphatase content after treatment of the study group was significantly decreased compared with that before treatment and it was lower than that after treatment of the control group （P0.05）. Bone mineral density after treatment of the study group was significantly increased compared with that before treatment and it was higher than that after treatment of the control group （P0.05）. Conclusion Application of Bushen Tongluo scheme in treatment of primary osteoporosis has significant clinical effect. It can improve bone detection indexes of laboratory and prognosis of patients which can be promoted and applied in clinical treatment. 　　[Key words] Primary osteoporosis； Bu